DSM Sinochem Pharmaceuticals


Jamieson advised CEO Karl Rotthier and the DSP management team on their investment alongside Bain and the equity incentive arrangements in the new holding structure.

DSP is headquartered in Singapore and was formed out of a joint venture between DSM, a Dutch multinational, and Sinochem, a Chinese conglomerate. The business specialises in the development and production of substances used in pharmaceuticals manufacturing.

John Greenland, Andrew Cox and Gus Gayford of Jamieson advised the DSP team on the commercial and economic terms of the equity incentive and the managers’ investment alongside Bain in the new capital structure.